SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-014954
Filing Date
2022-10-12
Accepted
2022-10-12 11:43:50
Documents
14
Period of Report
2022-10-10
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20221010x8k.htm   iXBRL 8-K 41588
2 EX-16.1 tmb-20221010xex16d1.htm EX-16.1 5946
3 GRAPHIC tmb-20221010xex16d1002.jpg GRAPHIC 31393
  Complete submission text file 0001558370-22-014954.txt   201955

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20221010.xsd EX-101.SCH 3031
5 EX-101.LAB tmb-20221010_lab.xml EX-101.LAB 14083
6 EX-101.PRE tmb-20221010_pre.xml EX-101.PRE 9201
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20221010x8k_htm.xml XML 4351
Mailing Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746
Business Address 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA 01746 (774) 233-7300
Biostage, Inc. (Filer) CIK: 0001563665 (see all company filings)

IRS No.: 455210462 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35853 | Film No.: 221305971
SIC: 3841 Surgical & Medical Instruments & Apparatus